Search Details

Word: nih (lookup in dictionary) (lookup stats)
Dates: during 2000-2009
Sort By: most recent first (reverse)


Usage:

Nobody likes a busy signal. And for U.S. stem-cell researchers, none has been more frustrating than the one on the National Institutes of Health's (NIH) Human Embryonic Stem Cell Registry home page. That's where the government agency lists all of the embryonic-stem-cell lines that scientists are allowed to study using taxpayer dollars. For months, the page has been depressingly static. "None are available at this time," it read. "Please check back later...

Author: /time Magazine | Title: U.S. Allows New Stem-Cell Lines for Research | 12/2/2009 | See Source »

Nabel, who Moriarty said emphasized patient care during her term at NIH, has also worked personally with local residents in Washington, D.C. This experience, he said, has prepared her to lead a premier research institution that also serves as a community hospital for the Jamaica Plain, Dorchester, and Roxbury neighborhods...

Author: By Laura G. Mirviss, CRIMSON STAFF WRITER | Title: Nabel To Lead Two Boston Hospitals | 10/26/2009 | See Source »

...happened again on Saturday when researchers learned that the first ever successful AIDS vaccine turned out not to be the triumph they had originally hoped. In September, scientists from the National Institutes of Health (NIH) and the U.S. Army announced the results of an AIDS-vaccine study in Thailand involving more than 16,000 volunteers. The data showed that the new vaccine had protected 31% of inoculated participants from becoming infected with HIV. But a closer look at a subset of the study's volunteers now reveals that the vaccine in fact protected only 26% of the people who received...

Author: /time Magazine | Title: Behind the Rising Doubts About Hailed AIDS Vaccine | 10/13/2009 | See Source »

From the outset, the vaccine strategy used in the NIH and U.S. Army study - giving two older vaccines in succession - has been controversial. In previous trials, each vaccine had failed to provide any protection against HIV, and in September 2004 a group of adamant scientists wrote a letter to Science arguing that the National Institute of Allergy and Infectious Diseases should not to continue with the trial. "We seriously question whether it is sensible now to conduct a ... trial that, in our opinion, is no more likely to generate a meaningful level of protection against infection or disease," they wrote...

Author: /time Magazine | Title: Behind the Rising Doubts About Hailed AIDS Vaccine | 10/13/2009 | See Source »

According to Ausubel, the NIH grants allow researchers to develop hypotheses that are “compelling yet may not be correct...

Author: By Sophie A. Fry, CONTRIBUTING WRITER | Title: NIH Grants Fund 18 ‘High Risk’ Harvard Projects | 9/28/2009 | See Source »

Previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | Next